Integration of the Pharmaceutical Manufacturing and Sales Business segment into Other Businesses
First written in FY2024-Q1. 3 of 4 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1RestatedAnnual report
「From the first quarter of the current fiscal year, the pharmaceutical manufacturing and marketing business, which had previously been presented as a reportable segment, has been included in Other businesses because it has become immaterial in amount.」
The pharmaceutical manufacturing and marketing business continues to be included in Other businesses as a reportable-segment reclassification due to its reduced materiality in amount. - FY2024-Q3RestatedAnnual report
「From the first quarter of the current fiscal year, the pharmaceutical manufacturing and marketing business, which had previously been presented as a reportable segment, has been included in Other businesses because it has become immaterial in amount.」
The pharmaceutical manufacturing and marketing business continues to be included in Other businesses as a reportable-segment reclassification due to its reduced materiality in amount. - FY2024-Q2RestatedAnnual report
「From the first quarter of the current fiscal year, the pharmaceutical manufacturing and marketing business, which had previously been presented as a reportable segment, has been included in Other businesses because it has become immaterial in amount.」
The pharmaceutical manufacturing and marketing business continues to be included in Other businesses as a reportable-segment reclassification due to its reduced materiality in amount. - FY2024-Q1First statedAnnual report
「From the first quarter of the current fiscal year, the pharmaceutical manufacturing and marketing business, which had previously been presented as a reportable segment, has been included in Other businesses because it has become immaterial in amount.」
The pharmaceutical manufacturing and marketing business was reclassified from a reportable segment to Other businesses because it had become immaterial in amount.